Percentage of participants reporting SAEs classified by MedDRA primary organ class and preferred term over 14 months follow-up.

N  =  number of subjects with at least one administered dose and included in ITT cohort.
n/%  =  number/percentage of subject reporting at least once the symptom.
*Symptoms reported by a subject after a given dose and classified by the same Preferred Term are counted once.